Suppr超能文献

吡罗昔康与布洛芬治疗类风湿性关节炎的双盲对照研究。

A double-blind comparative study of piroxicam and ibuprofen in the treatment of rheumatoid arthritis.

作者信息

McLaughlin G E

出版信息

Semin Arthritis Rheum. 1985 Feb;14(3 Suppl 1):11-3. doi: 10.1016/0049-0172(85)90054-x.

Abstract

Recommended dosages of nonsteroidal anti-inflammatory drugs have increased considerably since their introduction. The maximum recommended dosage for ibuprofen, a widely prescribed drug for the treatment of rheumatoid arthritis, has increased from 400 mg three or four times a day (at the time of its introduction) to 2,400 mg per day at present. Piroxicam at 20 mg per day was compared with ibuprofen at 2,400 mg per day in 20 patients with rheumatoid arthritis. Both drugs were found to be effective, with similar side-effect profiles.

摘要

自非甾体抗炎药问世以来,其推荐剂量已大幅增加。布洛芬是一种广泛用于治疗类风湿性关节炎的药物,其最大推荐剂量已从问世时的每日三或四次、每次400毫克增加到目前的每日2400毫克。对20例类风湿性关节炎患者进行了比较,一组患者每天服用20毫克吡罗昔康,另一组患者每天服用2400毫克布洛芬。结果发现两种药物均有效,且副作用相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验